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Summary
Diclofenac is one of the most commonly detected
pharmaceuticals in wastewater treatment plant
(WWTP) effluents and the receiving water bodies. In
this study, biogenic Pd nanoparticles (‘bio-Pd’) were
successfully applied in a microbial electrolysis cell
(MEC) for the catalytic reduction of diclofenac. Hydro-
gen gas was produced in the cathodic compartment,
and consumed as a hydrogen donor by the bio-Pd on
the graphite electrodes. In this way, complete dechlo-
rination of 1 mg diclofenac l-1 was achieved during
batch recirculation experiments, whereas no signifi-
cant removal was observed in the absence of
the biocatalyst. The complete dechlorination of
diclofenac was demonstrated by the concomitant pro-
duction of 2-anilinophenylacetate (APA). Through the
addition of -0.8 V to the circuit, continuous and com-
plete removal of diclofenac was achieved in synthetic
medium at a minimal HRT of 2 h. Continuous treat-
ment of hospital WWTP effluent containing 1.28 mg
diclofenac l-1 resulted in a lower removal efficiency of
57%, which can probably be attributed to the affinity
of other environmental constituents for the bio-Pd
catalyst. Nevertheless, reductive catalysis coupled to
sustainable hydrogen production in a MEC offers
potential to lower the release of micropollutants from
point-sources such as hospital WWTPs.
Introduction
Diclofenac [2-(2,6-dichloranilino)phenylacetic acid] is a
widely utilized non-steroidal and anti-inflammatory drug,
used as an analgesic (Zhang et al., 2008). After human
consumption, diclofenac is almost completely excreted in
urine. Because of its limited sorption and its low biode-
gradability, the removal of diclofenac in conventional
wastewater treatment plants (WWTPs) is generally limited
to 30% and thus diclofenac enters the environment
through WWTP discharges (Ternes et al., 2004; Joss
et al., 2006). As a consequence, diclofenac is very often
detected in WWTP effluents (in mg l-1), the receiving
surface waters and even in tap water (in ng l-1) (Ternes,
1998; Heberer, 2002). Since it has been shown to inter-
fere with the biochemical functions of fish and causes
tissue damage at environmentally relevant concentrations
(Mehinto et al., 2010), diclofenac may be considered as
one of the most relevant compounds with respect to the
persistence of pharmaceuticals in the environment.
According to the precautionary principle, the environmen-
tal input of such persistent and long-living, mobile com-
pounds should be limited.
Advanced oxidation processes (AOP) such as
UV/H2O2 and O3 have been demonstrated to effectively
remove diclofenac from WWTP effluents (Ternes et al.,
2003). However, an increase in toxic and mutagenic
compounds after ozonation has been shown, probably
related to the production of intermediates such as
N-nitrosodimethylamine (NDMA), hydroxylamines or
aldehydes (Guzzella et al., 2002; Schmidt and Brauch,
2008; Benner and Ternes, 2009). As an alternative to
AOP, reductive treatment using metal catalysts is cur-
rently under investigation. Biogenic Pd nanoparticles
(‘bio-Pd’) have been demonstrated to be potent catalysts
for the dechlorination of chlorinated solvents and PCBs
(Hennebel et al., 2009a), but the use of bio-Pd catalysis
for the dechlorination of diclofenac has not been
explored yet. To support the catalytic hydrodehalogena-
tion reaction, an external hydrogen donor is required.
Hydrogen gas (H2) was shown to be the most effective
reactant (Hennebel et al., 2009b), because Pd catalysts
are able to convert H2 to adsorbed atomic hydrogen,
which is a powerful reducing agent (Mackenzie et al.,
2006).
Because the external supply of H2 can give rise to
technical difficulties, it is still the limiting factor for continu-
ous treatment of chlorinated pollutants by bio-Pd cataly-
sis. Recently, microbial electrolysis cells (MECs) have
been developed as a safe route for H2 production and
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supply (Rozendal et al., 2006; Huang et al., 2011). This
technique provides in situ produced H2-gas, which can
immediately be used as hydrogen donor to activate the
bio-Pd. This elegant solution allows continuous dosage of
hydrogen, which was one of the major challenges for the
implementation of bio-Pd technology until now (Hennebel
et al., 2009b; 2011). In the anodic compartment of such a
MEC, organic substrates are oxidized by electrochemi-
cally active bacteria that pass the electrons to the anode.
These electrons are transported through an external
circuit to the cathode, where they can be consumed for H2
production (Rozendal et al., 2006). To force the electrons
to migrate to the cathodic compartment, a supplemental
voltage needs to be supplied to the electrical circuit.
The aim of this study was to examine the applicability of
bio-Pd to catalyse the dechlorination of diclofenac. In
order to supply H2 as hydrogen donor to the biocatalysts,
a MEC was used and recirculation experiments were con-
ducted at different cell voltages, aiming at complete deha-
logenation of the model compound. The latter has been
investigated by monitoring of the fully dechlorinated trans-
formation product 2-anilinophenylacetate (APA). Further-
more, the use of the MEC system for the continuous
removal of diclofenac was examined in both synthetic
medium and hospital WWTP effluent, an important point-
source of absorbable organic halogens (AOX).
Results and discussion
H2 production by a MEC supports the bio-Pd catalysis
of diclofenac
Batch recirculation experiments were conducted with the
MEC to treat synthetic medium with 1 mg diclofenac l-1.
The graphite electrodes in the cathodic compartment
were coated with 5 mg bio-Pd g-1 graphite. When a
voltage of -0.4 V was applied to the MEC, 92  10%
removal was achieved after 24 h of recirculation (Fig. 1).
The mean cathode potential was -570  63 mV versus
SHE (Table 1), and at that potential H2 production was
detected at the cathode (data not shown). No significant
removal was achieved with the bio-Pd MEC in open circuit
and no gas production could be observed in that case.
Our results demonstrate the importance of sufficient H2
supply to the bio-Pd catalysts, and the necessity of apply-
ing an external potential to the MEC to facilitate H2 pro-
duction at the cathode. Rozendal and colleagues (2006)
already reported on the production of H2 at an applied
voltage of -0.5 V, and they expected a decrease to
-0.4 V or -0.3 V by an improvement of the MEC design.
In the present study, a packed bed with graphite granules
was applied as electrodes, which offers a high surface
area (1.3 m2 g-1) to electrochemically active microorgan-
isms, and increases the electricity output and conversion
of acetate to hydrogen gas (Wang et al., 2010). Further-
more, the presence of the Pd nanoparticles themselves in
the cathode are known to facilitate hydrogen production
by a MEC by lowering of the cathode overpotential
(Huang et al., 2011). Because of various electrochemical
losses, the required voltage was higher than the theoreti-
cally -0.14 V but lower than the minimally required -1.6 V
for direct electrolysis of water (Rasten et al., 2003), which
is the major advantage of a MEC system.
The sustainable production of H2 at the cathode sup-
ports the catalytic removal of diclofenac by bio-Pd. The
use of a MEC to supply H2 to bio-Pd has been success-
fully demonstrated for the dehalogenation of the chlori-
nated solvent trichloroethylene and the iodinated contrast
medium diatrizoate as well (De Gusseme et al., 2011;
Hennebel et al., 2011). In these reports and in this study,
no removal of the model compounds was observed in the
open circuit experiment. Moreover, applying higher volt-
ages resulted in increasing removal rates: application of
-0.6 V and -0.8 V resulted in a complete removal of
diclofenac after 24 h and 3 h respectively (Fig. 1). This is
probably related to the higher production of H2 and thus
the faster supply of the reactant to the bio-Pd catalyst.
Higher H2 production rates with higher applied voltages
were previously described for other MEC configurations
as well (Cheng and Logan, 2007).
Complete dechlorination of diclofenac by
bio-Pd catalysis
In contrast to the high removal efficiency obtained in the
MEC with bio-Pd coated graphite, the diclofenac removal
Fig. 1. Percentage of diclofenac removal from synthetic medium as
a function of time, during the batch recirculation experiments using
the MEC with bio-Pd coated graphite granules in the cathode. The
MEC runs were performed at different applied voltages (-0.4, -0.6
and -0.8 V) and in open circuit. A control experiment at an applied
voltage of -0.8 V using non-coated graphite granules in the
cathode is included as well. Error bars represent the standard
deviation of triplicate measurements (sometimes smaller than
symbols).
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was only 3.5  0.2% after 24 h of recirculation in the MEC
with non-coated graphite electrodes, even when an exter-
nal voltage of -0.8 V was applied (Fig. 1). However, the
current production was comparable with the batch recir-
culation experiment in the MEC with bio-Pd coated graph-
ite (Table 1), and gas production was observed in the
cathode compartment, also at -0.4 V and at -0.6 V (data
not shown). This shows that the presence of the bio-Pd
catalyst was necessary for diclofenac removal, and that
the removal is not the result of straightforward electro-
chemical reduction in the MEC, as was the case for
trichloroethylene (Hennebel et al., 2011). Apparently,
dechlorination of diclofenac by direct electrochemical
reduction at bare graphite electrodes is not possible at a
cathode potential of -800  25 mV (Table 1). The impor-
tance of the presence of Pd for diclofenac removal has
been shown before under anoxic conditions. Ghauch and
colleagues (2010) could significantly improve the
diclofenac removal efficiency of an iron catalyst by coating
the surface of the Fe(0) particles with Pd.
By means of chromatographic analyses, we were able
to identify APA as the main transformation end-product
and the monodechlorinated diclofenac as intermediate.
However, the latter could not be quantified due to a lack of
a commercially available standard. From the structural
formula, it is clear that APA formation is the result of
straightforward reduction of the carbon atoms, eliminating
the two chloride substituents (Fig. 2). When a voltage of
-0.4 V was applied to the MEC, 2.6  0.1 mM diclofenac
(= 0.77  0.03 mg l-1) was removed after 24 h, corre-
sponding to a removal efficiency of 92  12% (initially
0.85  0.01 mg l-1 present). Concomitantly, 2.4  0.1 mM
APA (= 0.55  0.02 mg l-1) was detected, which means
that the mass balance could be closed for 92% (Fig. 2).
In case of an applied voltage of -0.6 or -0.8 V, all
diclofenac was transformed into APA after 24 and 3 h
respectively.
The occurrence of the fully dechlorinated APA was pre-
viously reported by Ghauch and colleagues (2010) as
well. Using PdFe catalysts under anoxic conditions, they
could detect APA during diclofenac removal, whereas no
dechlorinated products were discernible under oxic con-
ditions. Reductive catalysis thus offers the advantage of
complete dechlorination and the production of a single
product, while AOP may result in a wide variety of degra-
dation products and by-products, which can increase the
mutagenicity and toxicity of the wastewaters. This is in
contrast with the dechlorinated end-product APA. Indeed,
batch incubation tests using a nitrifying culture proved the
biodegradability (Material S2), which implies that APA
cannot (bio)accumulate and exert toxic or mutagenic
effects. During this experiment (Fig. S1), it was observed
that almost all APA was removed after 7 days of incuba-
tion, while the biomass-free and heat-inactivated controls
gave no degradation at all. Conclusively, dehalogenation
of micropollutants can significantly lower the AOX content
of WWTP effluents, rendering transformation products
that may be more biodegradable.








Batch run synthetic medium at -0.4 V -452  4 -570  63 308  53
Batch run synthetic medium at -0.6 V -599  6 -621  81 411  78
Batch run synthetic medium at -0.8 V -837  10 -743  42 428  58
Batch run synthetic medium at -0.8 V without bio-Pd -847  45 -800  25 454  93
Continuous run synthetic medium at -0.8 V, HRT = 0.5 h -787  2 -773  17 451  22
Continuous run synthetic medium at -0.8 V, HRT = 2 h -825  39 -849  23 434  10
Continuous run synthetic medium at -0.8 V, HRT = 4 h -827  36 -852  26 405  41
Continuous run synthetic medium at -0.8 V, HRT = 8 h -813  2 -883  74 481  17
Continuous run hospital WWTP effluent at -0.8 V, HRT = 8 h -808  4 -923  2 588  34
NCC, net cathodic compartment.
Fig. 2. Removal of diclofenac from synthetic medium and formation
of APA as a function of time in the batch recirculation experiment
using the MEC with bio-Pd coated graphite granules in the
cathode. A voltage of -0.4 V was applied and the error bars
represent the standard deviation of triplicate measurements
(sometimes smaller than symbols).
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Continuous dechlorination in synthetic medium and
hospital WWTP effluent
To examine the use of the MEC system for continuous
treatment of diclofenac, the synthetic medium was fed
continuously to the cathode compartment at different HRT
(Fig. 3). Applying a cell voltage of -0.8 V, a HRT of 0.5 h
was clearly too low to allow complete removal of
diclofenac. Between 3 and 48 h after start-up, an average
removal efficiency of 90  4% could be achieved. When a
HRT of minimally 2 h or a volumetric loading rate of
3 g diclofenac m-3 TCC day-1 was provided, all diclofenac
was removed. Moreover, APA was detected and at a HRT
of 2 h, the mass balance with diclofenac could be closed
for 96% after 48 h of operation.
At a longer HRT of 4 h, 95% of diclofenac could still be
recovered as APA but other transformation products were
detected by chromatographic analyses. The latter was
also the case at a HRT of 8 h and APA seemed to be
subjected to further reduction since the mass balance with
diclofenac could be closed for only 78% after 48 h. It
should be noted that no significant pH changes were
observed during the 48 h test runs, which may most prob-
ably be explained by the use of an anion exchange mem-
brane in the MEC. In contrast to a cation exchange
membrane, anion exchange membranes enhance proton
conduction by carrying protons by negatively charged
phosphate anions through the membrane (Cheng and
Logan, 2007). In this way, elevation of the pH at the
cathode and subsequent limiting of the hydrogen evolu-
tion reaction was prevented.
To lower the pharmaceutical load into the environment,
separate decentralized treatment at point-sources such
as hospitals has been suggested (Heinzmann et al.,
2008), especially because of the problems with AOP
described above. In order to examine the performance
of the MEC for the treatment of diclofenac in such an
environmental matrix, a continuous experiment was
performed with a hospital WWTP effluent containing
1.28 mg diclofenac l-1 (Fig. 3). Applying a voltage of
-0.8 V and a HRT of 8 h, an average removal of 57  9%
was achieved between 24 and 48 h after start-up. This
removal efficiency is lower than what was achieved by
treatment of a spiked synthetic medium, which is most
probably related to the lower diclofenac concentrations
and the influence of interfering matrix compounds
and other reducible compounds such as nitrate
(28.85  0.02 mg NO3--N l-1 present in the hospital
WWTP effluent) (Shuai et al., 2010). Moreover, the efflu-
ent contained 30.50  0.04 mg SO42--S l-1, which can
influence the catalyst performance as well. Indeed, reduc-
tion of the latter might have resulted in the formation of
sulfide, which is known to poison Pd catalysts (Angeles-
Wedler et al., 2008).
Hospital WWTP effluents often contain a mixture of
recalcitrant and/or halogenated organics, and in this par-
ticular effluent, also diatrizoate (292  17 mg l-1) and
other iodocompounds were detected (total iodine concen-
tration of 2.7 mg I l-1). These iodocompounds are known
to compete with chlorocompounds for the catalytic sites at
the Pd surface (Mackenzie et al., 2006). Whereas diatri-
zoate was completely removed from this particular efflu-
ent using the MEC with bio-Pd (De Gusseme et al., 2011),
it is our hypothesis that the simultaneous hydrodechlori-
nation of diclofenac was (partially) inhibited by the pres-
ence of iodocompounds. Furthermore, the release of
halogenide ions might cause self-poisoning of the Pd
catalyst and hamper its long-term performance.
Before the bio-Pd based MEC system can be applied
for separate treatment of hospital effluents, future
research dealing with mixtures of halogenated micropol-
lutants is necessary to examine the lifetime of the catalyst,
and to further investigate how the different affinity of these
compounds for the catalyst influences their removal rates.
In addition, higher removal efficiencies in the environmen-
tal matrix need to be achieved, for example by application
of other catalysts to improve the hydrogen production
(e.g. a Ni foam cathode) or by bimetallic catalysts, such as
Pd plated on a zerovalent Fe support (Ghauch et al.,
2010; Jeremiasse et al., 2010).
Experimental procedures
Tested media and diclofenac stock solution
A synthetic electrolyte medium was prepared for
the MEC experiments containing 6 g Na2HPO4.2H2O l-1,
3 g KH2PO4 l-1, 0.1 g (NH4)2HPO4 l-1, 0.1 g Ca3(PO4)2 l-1 and
0.5 ml l-1 of a trace metal solution previously described by
Fig. 3. Continuous MEC experiments for the treatment of synthetic
medium and hospital WWTP effluent at an applied voltage of
-0.8 V. Different hydraulic retention times (HRT) in the cathodic
compartment were used for the treatment of the synthetic medium:
0.5, 2, 4 and 8 h, while for the hospital WWTP effluent only a HRT
of 8 h was provided. Error bars represent the standard deviation of
triplicate measurements (sometimes smaller than symbols).
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Rabaey and colleagues (2005). For the treatment of
diclofenac in this medium, 1 mg l-1 was supplemented to the
synthetic medium using a 5 g l-1 stock solution (Sigma-
Aldrich, Germany) in deionized water. The pH and the con-
ductivity of the effluent were 7.1 and 28.43  0.08 mS cm-1
respectively.
To examine the diclofenac removal in an environmental
matrix, the effluent of a hospital WWTP was sampled in dry
weather conditions on 8 December 2010. The WWTP exclu-
sively treats hospital wastewater by means of a conventional
activated sludge system and the final effluent is discharged
into a nearby surface water. The effluent sample contained
1.28  0.04 mg diclofenac l-1 (and 292  17 mg diatrizoate l-1
and a total iodine concentration of 2.7 mg I l-1). The pH
and the conductivity of the effluent were 7.2 and
2.30  0.02 mS cm-1 respectively.
Microbial electrolysis cell
The MEC was constructed with two Plexiglass frames
(12.5 ¥ 8 ¥ 1.5 cm per frame), which resulted in a total anodic
and cathodic compartment (TCC) of 0.150 l. Both compart-
ments were packed with 160 g of graphite granules (type
00514, f: 1.5–5 mm, Mersen, France), and in each of them,
a graphite rod current collector (f: 5 mm, Morgan, Belgium)
was provided to connect them with the external electrical
circuitry. Between the anodic and cathodic frames, a cation
exchange membrane was installed (Ultrex CMI7000, Mem-
branes International, NJ, USA) during the batch recirculation
experiments. A power source was used to supply an external
voltage between anode and cathode. The voltage difference
between both compartments, the voltage drop over a 1 W
resistor in circuitry and the cathode potential were registered
by a 34970A Data Acquisition Switch unit (Agilent, Belgium).
The cathode potential was measured by monitoring the
voltage difference between the cathode and an Ag/AgCl ref-
erence electrode (+0.197 V versus SHE).
Batch recirculation experiments
The synthetic medium was sparged with N2, brought into 2 l
vessels, and separately recirculated through the anodic
and cathodic compartment at 17 ml min-1 or 6.67 l l-1 TCC h-1.
Sodium acetate (2 g l-1) was added to the anode medium as
feed, and the cathodic medium was spiked with 1 mg di-
clofenac l-1. A batch recirculation experiment with non-coated
graphite granules was performed during 24 h at an applied
voltage of -0.8 V. Subsequently, the graphite granules in the
cathode were replaced by graphite granules, coated with
bio-Pd (5 mg Pd g-1 graphite) as previously described (Hen-
nebel et al., 2011). Batch MEC runs were performed in open
circuit, and in closed circuit at various applied voltages: -0.4,
-0.6 and -0.8 V. Before every test run, the MEC was con-
ditioned overnight to the applied voltage. After each experi-
ment, the anode and cathode medium were replenished.
Samples for analysis of H2, diclofenac and its transformation
product APA were taken at regular intervals.
Continuous experiments
For the continuous experiments, the cation exchange mem-
brane between the anodic and cathodic compartments was
replaced by an anion exchange membrane (AMI-7001,
Membranes International). Synthetic medium with 1 mg
diclofenac l-1 was continuously pumped through the cathodic
compartment with a net volume of 0.070 l. During operation,
the active volume was measured to be 0.035 l due to gas
accumulation. Different continuous experiments were per-
formed during 48 h, with a HRT of 0.5, 2, 4 and 8 h in the
cathodic compartment respectively. In the anodic compart-
ment, synthetic medium with 2 g l-1 sodium acetate was recir-
culated. The voltage supplied to the MEC was -0.8 V. In
addition, a hospital WWTP effluent was continuously pumped
through the cathodic compartment with a HRT of 8 h.
Samples were regularly taken for analysis of diclofenac and
APA.
Chromatographic analyses
For chromatographic analysis of diclofenac and the complete
dechlorinated compound APA in synthetic medium, 2 ml
samples were filtered over 0.22 mm filters (Millipore, MA,
USA) in a glass HPLC vial and stored at 4°C in the dark prior
to analysis. Both compounds were analysed on a Dionex
(CA, USA) HPLC system with a P580 pump, TCC-100
column oven, UV-DAD detector (UVD340S) and Chromeleon
6.8 software. Separation was performed on a Genesis C18
column (150 ¥ 4.6 mm, 4 mm, Alltech, Belgium) with a guard
column. The elution programme was isocratic at a flow rate
of 1 ml min-1, using 80% methanol and 20% deionized
water + 0.1% formic acid. The injection volume was 50 ml, the
column temperature was fixed at 40°C, and the detection
wavelengths for diclofenac and APA were 203 and 275 nm
respectively. The limit of detection (LOD) was determined at
100 mg l-1 for both compounds, based on the criterion that the
signal to noise ratio (S/N) had to be at least 3.
For the detection of diclofenac and APA at lower concen-
trations, ultra-high performance liquid chromatography
coupled to tandem mass spectrometry (U-HPLC-MS/MS)
was used. Chromatography was carried out on a Thermo
Scientific (CA, USA) Accela U-HPLC system comprising of a
quaternary pump and autosampler, equipped with a Nucleo-
dur C18 Pyramid column (100 ¥ 2 mm, 1.8 mm, Macherey-
Nagel, PA, USA). The details of the elution program and the
specific MS parameters are given in the Supporting Informa-
tion (Material S1.1 and Table S1). The limit of quantification
(LOQ) was determined at 10 mg l-1 as the lowest point of the
calibration curve.
The samples of hospital WWTP effluent were filtered and
stored as described above. For the detection of diclofenac in
this matrix, U-HPLC-MS/MS was performed as described
above. However, other SRM transitions and other specific MS
parameters were used, which are given in the Supporting Infor-
mation (Material S1.2 and Table S2). The LOQ was determined
at 50 ng l-1 as the lowest point of the calibration curve.
Chemical analyses
The presence of H2 in the gas phase of the cathodic com-
partment was qualitatively analysed by a Compact GC with a
thermal conductivity detector (Global Analyser Solutions, The
Netherlands), equipped with a PoraBOND Q pre-column and
a Molsieve 5A column (Varian). Because the cathodic
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medium was extensively sparged with N2 prior to the experi-
ments, N2 release from the medium significantly diluted the
gas samples. Conductivity was measured using a Consort
C833 multi-channel analyser with EC-electrode (Consort,
Belgium).
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Additional Supporting Information may be found in the online
version of this article:
Fig. S1. APA removal as a function of time during 7 days
incubation of ABIL biomass (0.75 g VSS l-1) in minimal
medium supplemented with 1 mg APA l-1. To examine
sorption of APA to the biomass, heat-inactivated biomass was
incubated in a control experiment (0.75 g VSS l-1). Results
from a biomass-free control in the minimal medium are also
shown.
Table S1. Collected SRM transitions and compound specific
MS parameters.
Table S2. Collected SRM transitions and compound specific
MS parameters for the detection in the samples of the hos-
pital WWTP effluent.
Material S1. Details of U-HPLC-MS/MS analyses.
Material S2. Biodegradability of APA.
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